Panacea Biotec Ltd. is up 1.30% to Rs 424.85, extending recent gains and rising 0.24% over the last one week. Panacea Biotec Ltd. has received a Letter of Award from UNICEF for the supply of bivalent Oral Polio Vaccine (bOPV) in Calendar Year 2028, valued at approximately US$8.205 million (Rs 78.24 Crore), as part of a Long-Term Agreement initiated in April 2026. This award, for both 10 and 20 dose presentations, follows a previous award announced on October 3, 2025, and represents an international contract for the supply of bOPV to UNICEF. Trading volume reached 1.46 lakh shares today, a marginal increase of 10.03% compared to the average volume over the past week. Panacea Biotec Ltd. edged up by 0.89% year-over-year, outperforming the NIFTY50 index's 0.44% loss.
